CHNA
Loncar China BioPharma ETFAUM$10.0M
Expense Ratio0.79%
NAV$9.77
Holdings57
InceptionAug 15, 2018
Price Chart
Key Statistics
Previous Close
N/ADay Range
N/A52-Week Range
N/AAvg Volume
N/ADividend Yield
N/AExpense Ratio
0.79%AUM
$10.0MShares Outstanding
N/ASector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 87.50% |
| United States | 6.10% |
| China | 5.11% |
| Hong Kong | 1.29% |
Fund Information
- Category
- Healthcare
- Subcategory
- Biotech
- Inception Date
- Aug 15, 2018
- Description
- The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Similar ETFs
The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that launched on Aug 15, 2018. It currently manages $10.0M in assets under management. The fund charges an expense ratio of 0.79%. The fund holds 57 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 28.6% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | 9939 | — | 4.42% | 109,500 | $440K |
| 2 | 1548 | — | 3.88% | 166,000 | $387K |
| 3 | 2196 | — | 3.25% | 77,500 | $324K |
| 4 | 1093 | — | 3.00% | 340,880 | $299K |
| 5 | 6185 | — | 2.57% | 9,800 | $256K |
| 6 | 867 | — | 2.39% | 158,000 | $238K |
| 7 | 3759 | — | 2.36% | 17,900 | $235K |
| 8 | 9966 | — | 2.26% | 145,000 | $225K |
| 9 | 2096 | — | 2.25% | 250,000 | $224K |
| 10 | 1177 | — | 2.24% | 384,500 | $223K |
| 11 | 460 | — | 2.24% | 890,000 | $223K |
| 12 | 2269 | — | 2.15% | 25,000 | $214K |
| 13 | 9969 | — | 2.12% | 113,000 | $211K |
| 14 | LEGN | Legend Biotech Corporation | 2.06% | 9,651 | $205K |
| 15 | 2359 | — | 2.01% | 16,857 | $200K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | N/A | — | ||
| 1W | N/A | — | ||
| 1M | N/A | — | ||
| 3M | N/A | — | ||
| 6M | N/A | — | ||
| YTD | N/A | — | ||
| 1Y | N/A | — | ||
| 3Y | -24.88% | — | ||
| 5Y | -62.63% | — |
Moving Averages
20-Day MA
N/A
50-Day MA
N/A
200-Day MA
N/A
Price with Moving Averages
Support & Resistance
52-Week High
N/A
Current Price
N/A
52-Week Low
N/A
Current Yield
N/A
Annual Dividend
N/A
Frequency
N/A
Last Ex-Date
N/A
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | CHNA | Healthcare(223 ETFs) | Biotech(39 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.79% | 0.60% | 0.84% |
| AUM | $10.0M | $1.25B | $1.62B |
| Dividend Yield | — | 2.75% | 14.38% |
| Avg Volume | N/A | 769.9K | 1.3M |
| Holdings | 57 | 182 | 67 |
| Performance | |||
| 1-Month Return | — | -3.02% | -2.05% |
| 6-Month Return | — | +5.85% | +15.05% |
| YTD Return | — | +0.17% | +1.05% |
| 1-Year Return | — | +16.65% | +24.43% |
Compare with Another ETF
Search for an ETF to compare with CHNA: